Clinical Trial Update: Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 clinical trial of EYE001 for wet age-related macular degeneration (NCT00150202). The study status is reported as Completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• EYE001

Snippet

Sponsor: Pfizer | Conditions: Macular Degeneration | Phase 3 | Status: COMPLETED